Home / Stocks / CVS

CVS Health (CVS, Health Care Services) Stock Valuation & Fair Value Fairly valued

CVS Health (CVS, Health Care Services) trades at a blended P/E of 12.4, about 9% below its historical normal valuation, with a forward growth estimate of 10.8% and a PEG of 1.14. Analysts' one-year estimates have been hit 64% of the time.

DATA AS OF 2026-08-21
Blended P/E
12.4
Normal P/E
13.5
PEG
1.14
Fwd growth
10.8%
Div yield
2.8%
RSI (14)
37.5
Neutral

The Street vs SeerForecast

Wall Street's mean price target for CVS is $116.08 across 25 analysts, 24.8% above the current price. The average analyst rating is Strong Buy. Our SeerForecast read of the same stock, formed without analyst targets: fairly valued. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating has been fairly valued since 2026-06-03.

Price and rating by weekClose moved +7.0 percent from 2026-06-03 to 2026-08-17, with 0 rating changes over 21 recorded weeks.2026-06-03: Fairly valued, close 90.81 (recalculated)2026-06-10: Fairly valued, close 97.42 (recalculated)2026-06-14: Fairly valued, close 101.33 (recalculated)2026-06-16: Fairly valued, close 100.10 (recalculated)2026-06-21: Fairly valued, close 97.72 (recalculated)2026-07-02: Fairly valued, close 104.08 (recalculated)2026-07-06: Fairly valued, close 101.45 (recalculated)2026-07-09: Fairly valued, close 102.18 (recalculated)2026-07-12: Fairly valued, close 103.51 (recalculated)2026-07-13: Fairly valued, close 105.25 (recalculated)2026-07-14: Fairly valued, close 105.53 (recalculated)2026-07-20: Fairly valued, close 106.95 (recalculated)2026-07-22: Fairly valued, close 107.42 (recalculated)2026-07-25: Fairly valued, close 107.74 (recalculated)2026-07-27: Fairly valued, close 107.07 (recalculated)2026-07-31: Fairly valued, close 104.43 (recalculated)2026-08-03: Fairly valued, close 104.432026-08-07: Fairly valued, close 95.70 (recalculated)2026-08-10: Fairly valued, close 95.702026-08-14: Fairly valued, close 97.16 (recalculated)2026-08-17: Fairly valued, close 97.1691972026-06-032026-08-17
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

2026-06-03P/E 13.2-2%Fairly valued
2026-06-10P/E 13.6+1%Fairly valued
2026-06-14P/E 13.6+1%Fairly valued
2026-06-16P/E 13.6+1%Fairly valued
2026-06-21P/E 13.6+1%Fairly valued
2026-07-02P/E 14.8+9%Fairly valued
2026-07-06P/E 14.8+9%Fairly valued
2026-07-09P/E 14.8+9%Fairly valued
2026-07-12P/E 14.7+8%Fairly valued
2026-07-13P/E 14.7+8%Fairly valued
2026-07-14P/E 14.7+8%Fairly valued
2026-07-20P/E 15.1+12%Fairly valued
2026-07-22P/E 15.1+12%Fairly valued
2026-07-25P/E 15.1+12%Fairly valued
2026-07-27P/E 15.1+12%Fairly valued
2026-07-31P/E 14.7+9%Fairly valued
2026-08-03P/E 14.6+8%Fairly valued
2026-08-07P/E 12.8-5%Fairly valued
2026-08-10P/E 12.8-6%Fairly valued
2026-08-14P/E 12.6-7%Fairly valued
2026-08-17P/E 12.9-5%Fairly valued
2026-08-21P/E 12.4-9%Fairly valued ← now

Frequently asked questions

Is CVS Health stock overvalued?

At a blended P/E of 12.4 versus its historical normal P/E of 13.5, CVS Health trades about 9% below its typical valuation, with a PEG of 1.14 on 10.8% forward growth. tickerseer currently rates it fairly valued.

What is CVS Health's fair value and PEG?

CVS Health trades at a blended P/E of 12.4 against a historical normal P/E of 13.5, a PEG of 1.14, and a forward growth estimate of 10.8%.

Has tickerseer's rating of CVS Health changed?

tickerseer's rating has been fairly valued since 2026-06-03.

What is the analyst price target for CVS Health?

The mean Wall Street price target for CVS Health is $116.08 across 25 analysts, 24.8% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Health Care Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track CVS free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. Educational content, not investment advice.